Drug Pipeline

ML-007C-MA Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-20 NCT06887192
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's…		 Trial sites expanded: 26 -> 40 locations
Active Studies by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07459660 An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis Psychosis Associated With Alzheimer's Disease Recruiting
NCT07459647 A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia Schizophrenia Recruiting
NCT06887192 A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's… Psychosis Associated With Alzheimer's Disease Recruiting
Sponsors Running ML-007C-MA Trials
MapLight Therapeutics (3)
Disease Areas
Alzheimer's Disease (2) Schizophrenia (1)
Get alerts when ML-007C-MA trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free